Composition : Cabozantinib
Strength availability : 20mg
Form : capsules
Pack : 30 tablets

Cometriq 20mg which is a type of targeted therapy drug used to recover from medullary thyroid cancer and kidney cancer that has spread.
Its label contains a black box warning of gastrointestinal perforations, fistulas, and haemorrhage.
Cometriq 20mg is a prescription drug which is used under the supervision of doctors


Cometriq 20mg is used for the treatment of metastatic medullary thyroid cancer and for the treatment of patients having advanced renal cell carcinoma (RCC) who have getting before anti-angiogenic therapy.


Avoid substitute Cometriq tablets with Cabozantinib capsules.
The prescribed dose of Cometriq is 60 mg.
Administration Cometriq is without food.
Advise the patients not to eat for at least 2 hours before and 1 hour after taking cometriq. Follow the treatment until patient no longer experiences clinical benefit or experiences unacceptable toxicity.
Swallow Cometriq tablets whole. Do not crush Cometriq tablets.


Cabozantinib is also called as tyrosine kinase inhibitor (targeted therapy drug). It works by prohibiting the signals inside cancer cells which made them grow and multiple. This may help to block or reduced the growth of the cancer. It can also prohibit new blood vessels growing in the cancer. Cancer cells require to make new blood vessels, so they can develop and spread.


high plasma concentration is observed in 2-5 hours
bounding of Cometriq has human plasma protein ≥ 99.7%
Mainly metabolized by CYP3A4 and minorly by CYP2C9
eliminated mostly through feces 54 % and in urine 27% and half-life is 55 hours


Monitor the patients for symptoms of perforations and fistulas, contain abscess. stop Cometriq 20mg in patients who experience a perforation or a fistula.
Do not administer Cometriq 20mg to patients with a present history of haemorrhage or haemoptysis.
Discontinue the Cometriq 20mg in patients who develop an acute myocardial infarction, cerebral infarction, or any other clinically significant arterial thromboembolic complication.
Discontinue theCometriq 20mg for patient if have severe hypertension that cannot be controlled with anti-hypertensive therapy.
Inform pregnant women about possible harm to a foetus. Inform females of reproductive probable to use efficient contraception during treatment with Cometriq 20mg and for 4 months after the last dose.


Cometriq 20mg concomitant use with strong CYP3A4 inhibitor will increase the single dose plasma Cabozantinib exposure by 38%.
Cometriq 20mg concomitant use with strong CYP3A4 inducers will decreased the single dose plasma Cabozantinib exposure by 77%
Cometriq 20mg Combination with MRP2 inhibitors may increase the exposure to Cabozantinib


Cometriq 20mg is contraindicated patients having hypersensitivity reaction to the active substance or its excipients.


If the patient vomits after taking a dose of Cometriq 20mg or missed to take a dose, then should not to take an extra dose, but to take the next dose at the regular time, skip the missed dose. Do not take the missed dose within 12 hours of next dose.


Store the drug at 20℃ to 25℃
Keep away from the children resistances


• Thrombotic events
• Hypertension and hypertensive crisis
• Diarrhea
• Palmar-plantar erythrodysesthesia
• Reversible posterior leukoencephalopathy syndrome
• Haemorrhage
• GI perforations and fistulas

We'd Like to Hear From You!


1., a fully licensed and regulated pharmacy, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.
2. will not dispense any prescription medication without a valid prescription from a licensed physician.
3. If you are ordering prescription medication(s), you hereby confirm that you will send us a scanned copy of your valid prescription(s) via email, fax, Whatsapp, or by post, and this prescription shall then be subject to the scrutiny of and approval by our qualified Pharmacists.
4. The drug information provided in the is for informative purposes only and this Website is not intended to provide diagnosis, treatment or medical advice. We are not liable for any adverse effects or harm to you as a result of your reliance on the information in the Website.
5. requires either the User or Customer or the Caregiver to confirm he/she is completely aware of the indications, side effects, drug interactions, effects of missed dose or overdose of the medicines he/she orders from us. It is imperative to seek professional advice from your physician before purchasing or consuming any medicine from
6. At, a Caregiver can order prescription medicines on your behalf.

This information should not be used to decide whether to accept this product or any other medicine. Only a health care provider is knowledge and training to decide that a medicine suitable for a specific patient. This information does not support any drug as safe, are effective or approved for the treatment of any patient or health condition. It's simple a brief overview of general information about this product. It does not include all information on possible applications, indications, warnings, precautions, interactions, adverse effects or risks that may be relevant to this product. This information is not specific medical advice and does not replace information obtained from your health care provider. You should check with your health care provider for complete information about the risks and benefits of using this product.